364 related articles for article (PubMed ID: 21299628)
1. High-flux dialyzers, backfiltration, and dialysis fluid quality.
Schiffl H
Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
[TBL] [Abstract][Full Text] [Related]
2. Ultrapure dialysate for home hemodialysis?
Ouseph R; Ward RA
Adv Chronic Kidney Dis; 2007 Jul; 14(3):256-62. PubMed ID: 17603979
[TBL] [Abstract][Full Text] [Related]
3. Effects of dialysis purity on uremic dyslipidemia.
Schiffl H; Lang SM
Ther Apher Dial; 2010 Feb; 14(1):5-11. PubMed ID: 20438514
[TBL] [Abstract][Full Text] [Related]
4. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
Masakane I
Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
[TBL] [Abstract][Full Text] [Related]
5. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Ultrapure dialysate.
Ward RA
Semin Dial; 2004; 17(6):489-97. PubMed ID: 15660580
[TBL] [Abstract][Full Text] [Related]
8. Ultrapure dialysate: facts and myths.
Bommer J; Jaber BL
Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
[TBL] [Abstract][Full Text] [Related]
9. [Do convective treatments significantly reduce morbidity and mortality?].
Manzoni C; Cavalli A; Pontoriero G; Di Filippo S; Locatelli F
G Ital Nefrol; 2009; 26 Suppl 45():S16-9. PubMed ID: 19382089
[TBL] [Abstract][Full Text] [Related]
10. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
[TBL] [Abstract][Full Text] [Related]
11. When good water goes bad: how it happens, clinical consequences and possible solutions.
Lonnemann G
Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis.
Santoro A; Panzetta G; Tessitore N; Atti M; Mancini E; Esteban J; London G; Ara JM; Miguel JL; Neumann KH; Opatrny K; Perez R; Perrone B; Wizemann V; Zucchelli P
J Nephrol; 1999; 12(6):375-82. PubMed ID: 10626827
[TBL] [Abstract][Full Text] [Related]
13. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T
Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063
[TBL] [Abstract][Full Text] [Related]
14. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
15. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
Mandolfo S; Imbasciati E
G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
[TBL] [Abstract][Full Text] [Related]
16. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
Schiffl H
Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
[TBL] [Abstract][Full Text] [Related]
18. Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008.
Kawanishi H; Akiba T; Masakane I; Tomo T; Mineshima M; Kawasaki T; Hirakata H; Akizawa T
Ther Apher Dial; 2009 Apr; 13(2):161-6. PubMed ID: 19379157
[TBL] [Abstract][Full Text] [Related]
19. Ultrapure dialysis fluid: improving conventional and daily dialysis.
Ledebo I
Hemodial Int; 2004 Apr; 8(2):159-66. PubMed ID: 19379412
[TBL] [Abstract][Full Text] [Related]
20. The impact of membrane permeability and dialysate purity on cardiovascular outcomes.
Asci G; Tz H; Ozkahya M; Duman S; Demirci MS; Cirit M; Sipahi S; Dheir H; Bozkurt D; Kircelli F; Ok ES; Erten S; Ertilav M; Kose T; Basci A; Raimann JG; Levin NW; Ok E;
J Am Soc Nephrol; 2013 May; 24(6):1014-23. PubMed ID: 23620396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
